Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of AVAXIM and TRIMOVAX in Turkish Children
NCT00313950Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2006
- Primary completion
- Dec 2009
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis A virus vaccine in hepatitis A (HAV), sponsored by Sanofi. Started Sep 2006; status: completed.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00313950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313950.